X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23446) 23446
Newspaper Article (3555) 3555
Publication (2078) 2078
Newsletter (1239) 1239
Magazine Article (677) 677
Trade Publication Article (325) 325
Book Review (257) 257
Report (250) 250
Book / eBook (224) 224
Dissertation (141) 141
Book Chapter (130) 130
Web Resource (103) 103
Government Document (69) 69
Paper (55) 55
Conference Proceeding (45) 45
Transcript (40) 40
Data Set (19) 19
Reference (8) 8
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hypertension (22913) 22913
humans (16076) 16076
female (11131) 11131
male (10486) 10486
index medicus (10206) 10206
middle aged (8638) 8638
risk factors (8124) 8124
adult (7718) 7718
blood pressure (6909) 6909
aged (6543) 6543
diabetes (5465) 5465
prevalence (4861) 4861
mortality (4219) 4219
research (4111) 4111
socioeconomic factors (4014) 4014
cardiovascular disease (3757) 3757
hypertension - epidemiology (3694) 3694
obesity (3616) 3616
studies (3506) 3506
population (3181) 3181
health aspects (3125) 3125
public health (3067) 3067
public, environmental & occupational health (2935) 2935
medicine (2888) 2888
epidemiology (2804) 2804
analysis (2699) 2699
research article (2676) 2676
cross-sectional studies (2635) 2635
blood-pressure (2617) 2617
hypertension - drug therapy (2528) 2528
adolescent (2506) 2506
body mass index (2489) 2489
health (2364) 2364
medicine, general & internal (2304) 2304
cardiovascular diseases (2272) 2272
care and treatment (2238) 2238
risk (2228) 2228
medical research (2223) 2223
patients (2161) 2161
disease (2131) 2131
aged, 80 and over (2042) 2042
young adult (2030) 2030
prevention (1967) 1967
antihypertensive agents - therapeutic use (1944) 1944
adults (1932) 1932
diabetes mellitus (1928) 1928
risk-factors (1844) 1844
age (1813) 1813
stroke (1752) 1752
peripheral vascular disease (1702) 1702
health risk assessment (1632) 1632
hospitals (1530) 1530
hypertension - complications (1507) 1507
smoking (1503) 1503
pregnancy (1495) 1495
health care (1489) 1489
management (1444) 1444
medicine, experimental (1434) 1434
age factors (1432) 1432
multidisciplinary sciences (1431) 1431
cardiovascular-disease (1416) 1416
chronic illnesses (1393) 1393
science (1344) 1344
cardiac & cardiovascular systems (1342) 1342
hypertension - economics (1328) 1328
womens health (1325) 1325
diet (1308) 1308
comorbidity (1306) 1306
diagnosis (1300) 1300
drug therapy (1231) 1231
surveys and questionnaires (1231) 1231
cost-benefit analysis (1228) 1228
cohort studies (1212) 1212
women (1205) 1205
retrospective studies (1191) 1191
cholesterol (1182) 1182
kidney diseases (1179) 1179
sex factors (1168) 1168
hypertension - physiopathology (1163) 1163
united-states (1161) 1161
nutrition (1150) 1150
metabolic syndrome (1148) 1148
united states (1143) 1143
article (1126) 1126
regression analysis (1126) 1126
cardiovascular diseases - epidemiology (1098) 1098
hypertension - diagnosis (1090) 1090
association (1087) 1087
treatment outcome (1076) 1076
exercise (1059) 1059
heart (1048) 1048
child (1038) 1038
prospective studies (1036) 1036
heart failure (1035) 1035
obesity - epidemiology (1008) 1008
hypertension - therapy (1004) 1004
education (998) 998
logistic models (998) 998
heart diseases (995) 995
usage (990) 990
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (112) 112
Online Resources - Online (12) 12
Robarts - Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
New College (Ivey) - Stacks (2) 2
Providence Healthcare - Stacks (2) 2
Scarborough Hospital - General (2) 2
St. Michael's Hospital - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Gerstein Science - Missing (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Media Commons - Microtexts (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
Women's College Hospital - Online (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (29003) 29003
Spanish (244) 244
Portuguese (209) 209
French (166) 166
Russian (129) 129
German (118) 118
Italian (40) 40
Swedish (37) 37
Chinese (33) 33
Polish (27) 27
Japanese (26) 26
Korean (22) 22
Turkish (12) 12
Norwegian (11) 11
Danish (10) 10
Hungarian (8) 8
Romanian (8) 8
Croatian (7) 7
Czech (7) 7
Dutch (5) 5
Urdu (4) 4
Arabic (3) 3
Hindi (3) 3
Lithuanian (3) 3
Persian (3) 3
Serbian (3) 3
Bulgarian (2) 2
Finnish (2) 2
Hebrew (2) 2
Ukrainian (2) 2
Afrikaans (1) 1
Bosnian (1) 1
Indonesian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2011, Directions in development. Human development, ISBN 9780821384879, xxix, 286
Latin America and the Caribbean will soon face the challenges of an aging population. This process, which took over a century in the rich world, will occur in... 
Older people | Economic aspects | Aged | Economic conditions | Social aspects | Health aspects | Population aging | Congresses | Caribbean Area | Latin America | CHRONIC CONDITIONS | LEADING CAUSE OF DEATH | INTERNATIONAL COMPARISONS | POPULATION RESEARCH | MORBIDITY | ACCESS TO HEALTH SERVICES | OFFICE OF POPULATION | HUMAN DEVELOPMENT | ECONOMIC GROWTH | POLICY FRAMEWORK | PUBLIC POLICY | DIABETES | LEVEL OF POVERTY | PURCHASING POWER PARITY | ELDERLY POPULATION | NATIONAL GOVERNMENTS | HEALTH SERVICES | MALARIA | AVERAGE FAMILY SIZE | NATIONAL LEVEL | HOUSEHOLD SURVEYS | INDIVIDUAL HEALTH | OLDER PEOPLE | SCHOOL-AGE POPULATION | MORTALITY | CHILD CARE | TUBERCULOSIS | IMPACT ON HEALTH | CENTER FOR HEALTH | INCOME SECURITY | INTERNATIONAL MIGRANTS | CHANGES IN POPULATION SIZE | DEVELOPING COUNTRIES | FERTILITY | UNITED NATIONS POPULATION DIVISION | OLDER PERSONS | LARGE POPULATION | HEALTH POLICY | WORKING-AGE POPULATION | SOCIAL POLICY | PANDEMIC | POPULATION GROWTH | AGING | PUBLIC EDUCATION | PERSONS WITH DISABILITIES | HEALTH CARE UTILIZATION | POPULATION MOMENTUM | HEALTH EXPENDITURES | DEMOGRAPHIC TRENDS | LEADING CAUSES OF DEATH | LEVELS OF PRODUCTIVITY | PURCHASING POWER | SERVICE UTILIZATION | FEMALE LIFE EXPECTANCY | POPULATION FIELD | OLD-AGE | INFANT MORTALITY RATE | DEMOGRAPHIC CHANGES | REPLACEMENT LEVEL | DEMOGRAPHERS | FAMILIES | LACK OF ACCESS TO TREATMENT | DISABILITY | FAMILY MEMBERS | ADULT POPULATION | INFANT | POLIO | INFECTIOUS DISEASES | EUROPEAN IMMIGRATION | HEALTH SYSTEM | LABOR MARKET | HUMAN IMMUNODEFICIENCY VIRUS | OBESITY | HOSPITAL | POPULATION STUDIES | LOW FERTILITY | NUMBER OF BIRTHS | POOR NUTRITION | SPOUSE | YOUNG ADULTS | COMMUNICABLE DISEASES | HEALTH STATUS | ECONOMIC DEMOGRAPHY | MAJORITY OF CHILDREN | HEALTH CARE DEMAND | LABOR SUPPLY | HEALTH COSTS | ILLNESS | RURAL AREAS | RURAL POPULATION | FERTILITY LEVELS | CARDIOVASCULAR DISEASE | AGE DISTRIBUTION | NATIONAL HEALTH SYSTEMS | PROGRESS | SECONDARY EDUCATION | URBAN POPULATION | HYPERTENSION | PENSIONS | MIGRATION | WORLD HEALTH ORGANIZATION | HEALTH CARE EXPENDITURES | FERTILITY RATE | SOCIAL INSTITUTIONS | DEPENDENCY RATIO | DECLINE IN FERTILITY | POPULATION GROWTH RATES | POLICY RESEARCH | YOUNG PEOPLE | HEALTH CARE | POPULATION ESTIMATES | IMPLICATIONS FOR HEALTH | FERTILITY RATES | REMITTANCES | GROSS DOMESTIC PRODUCT | RECIPIENT COUNTRIES | INFANT MORTALITY RATES | INDIVIDUAL INCOMES | INTEREST IN POPULATION | WORKFORCE | IMMIGRANTS | SOCIAL DEVELOPMENT | WORKERS | FERTILITY TRANSITIONS | CHILDREN PER WOMAN | CHRONIC DISEASE | IMPACT OF POPULATION | DISSEMINATION | LARGE POPULATIONS | LARGE FAMILIES | NUTRITION | PUBLIC HEALTH | FERTILITY DECLINE | HIGH SCHOOL EDUCATION | RISK FACTORS | DEPENDENT CHILDREN | SLOWER POPULATION GROWTH | ISOLATION | INCOME | MIGRANTS | AGED | DISABILITIES | OPPORTUNITIES FOR WOMEN | HEALTH CONDITIONS | POPULATION AND DEVELOPMENT | ELDERLY | ADULT MORTALITY | HOSPITALIZATION | PROBABILITY | HIV | LEGAL STATUS | ILL HEALTH | LEGISLATORS | ECONOMIC STATUS | MEDICAL NEEDS | CARDIOVASCULAR DISEASES | HEALTH PROBLEMS | WOMAN | LEVELS OF EDUCATION | MANAGEMENT OF HEALTH | YOUNG CHILDREN | LEADING CAUSES OF MORTALITY | SOCIAL EXPENDITURES | POPULATION GROUPS | REPRODUCTIVE AGE | POLICY DECISIONS | LIFE EXPECTANCY | LIVING CONDITIONS | DEMOGRAPHIC TRANSITION | POLICY CHANGE | POPULATION DISTRIBUTION | VIRGIN | PARASITIC DISEASES | PUBLIC SERVICES | INDIGENOUS POPULATIONS | DEPENDENCY RATIOS | ADEQUATE HEALTH CARE | DECLINES IN MORTALITY | LEADING CAUSES | IMMUNODEFICIENCY | LABOR FORCE | SOCIAL SECURITY | TRAUMA | WORLD CONFERENCE | URBAN CENTERS | OLDER ADULTS | IMMIGRATION COUNTRIES | INVESTMENT IN EDUCATION | CITIES | OLD AGE | SOCIAL WELFARE | CHILD MORTALITY | HEALTH FACILITIES | NUMBER OF CHILDREN | CHALLENGES OF POPULATION | POPULATION CHANGE | DEMOGRAPHIC CHANGE | HEALTH PLANS | LONG-TERM CARE | UNEMPLOYMENT | ECONOMIC IMPLICATIONS | POPULATION DIVISION | YOUNG AGES | RESPIRATORY DISEASES | POPULATION STRUCTURE | INFANT MORTALITY | WORLD POPULATION | POLICY MAKERS | SPOUSES | AGING POPULATIONS | POPULATION ISSUES | SOCIAL AFFAIRS | COUNTRIES OF ORIGIN
Book
BJOG: An International Journal of Obstetrics & Gynaecology, ISSN 1470-0328, 01/2014, Volume 121, Issue 1, pp. 72 - 82
Journal Article
Diabetes/Metabolism Research and Reviews, ISSN 1520-7552, 10/2015, Volume 31, Issue 7, pp. 707 - 716
Background Increasing diabetes prevalence affects a substantial number of pregnant women in the United States. Our aims were to evaluate health outcomes,... 
cost‐effectiveness | type 1 diabetes | type 2 diabetes | diabetes complications | gestational diabetes | pregnancy | Pregnancy | Type 2 diabetes | Gestational diabetes | Diabetes complications | Type 1 diabetes | Cost-effectiveness | cost-effectiveness | WOMEN | ENDOCRINOLOGY & METABOLISM | OUTCOMES | MELLITUS | Diabetes Mellitus, Type 1 - epidemiology | Congenital Abnormalities - epidemiology | Anemia - epidemiology | United States | Humans | Middle Aged | Cesarean Section - statistics & numerical data | Stillbirth - economics | Diabetes Mellitus, Type 2 - economics | Diabetes, Gestational - epidemiology | Diabetes, Gestational - economics | Pregnancy Outcome - epidemiology | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Pregnancy Complications, Cardiovascular - economics | Young Adult | Abortion, Spontaneous - epidemiology | Pregnancy Complications, Hematologic - economics | Adult | Congenital Abnormalities - economics | Female | Retrospective Studies | Pregnancy Complications, Infectious - economics | Infant, Newborn | Depression - epidemiology | Pregnancy Complications, Cardiovascular - epidemiology | Pregnancy Complications, Infectious - epidemiology | Pregnancy Outcome - economics | Cesarean Section - economics | Pregnancy in Diabetics - economics | Heart Defects, Congenital - economics | Health Care Costs | Abortion, Spontaneous - economics | Diabetes Mellitus, Type 1 - economics | Pregnancy in Diabetics - epidemiology | Depression - economics | Adolescent | Stillbirth - epidemiology | Anemia - economics | Heart Defects, Congenital - epidemiology | Pregnancy Complications, Hematologic - epidemiology | Hypertension | Genetic disorders | Pregnant women | Health aspects | Medical care, Cost of | Diabetes
Journal Article
Kidney International, ISSN 0085-2538, 03/2018, Volume 93, Issue 3, pp. 753 - 760
Catheter-related infections and dysfunction are the main catheter complications causing morbidity and mortality in hemodialysis patients. However, there are no... 
hemodialysis | tunneled catheter | taurolidine | catheter dysfunction | catheter-related infection | urokinase | ONCOLOGY-GROUP | METAANALYSIS | 4-PERCENT | PREVENTION | RANDOMIZED CONTROLLED-TRIAL | ANTIMICROBIAL LOCK | HEPARIN | TRISODIUM CITRATE | BACTEREMIA | UROLOGY & NEPHROLOGY | VASCULAR ACCESS | Drug Costs | Urokinase-Type Plasminogen Activator - therapeutic use | Prospective Studies | Taurine - economics | Humans | Middle Aged | Anticoagulants - economics | Heparin - therapeutic use | Male | Renal Dialysis - economics | Thiadiazines - adverse effects | Catheters, Indwelling - economics | Equipment Design | Thiadiazines - therapeutic use | Catheter-Related Infections - prevention & control | Thiadiazines - economics | Cost Savings | Austria | Time Factors | Fibrinolytic Agents - therapeutic use | Catheters, Indwelling - adverse effects | Catheter Obstruction - etiology | Heparin - economics | Adult | Female | Catheter-Related Infections - diagnosis | Taurine - therapeutic use | Catheterization, Central Venous - adverse effects | Taurine - adverse effects | Taurine - analogs & derivatives | Anti-Infective Agents - adverse effects | Catheter-Related Infections - economics | Risk Factors | Anti-Infective Agents - therapeutic use | Anticoagulants - therapeutic use | Central Venous Catheters - adverse effects | Treatment Outcome | Catheterization, Central Venous - economics | Central Venous Catheters - economics | Fibrinolytic Agents - economics | Catheter-Related Infections - microbiology | Cost-Benefit Analysis | Anti-Infective Agents - economics | Aged | Urokinase-Type Plasminogen Activator - economics | Catheter Obstruction - economics | Catheterization, Central Venous - instrumentation | Equipment Failure | Hypertension | Comorbidity | Hemodialysis | Cardiovascular disease | Infections | Catheters | Morbidity | Citric acid | U-Plasminogen activator | Studies | Microorganisms | Antibiotics | Diabetes | Kidney diseases | Heparin | Veins & arteries
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 05/2002, Volume 287, Issue 19, pp. 2542 - 2551
CONTEXT Several treatment interventions can reduce complications of type 2 diabetes, but their relative cost-effectiveness is not known. OBJECTIVE To estimate... 
UNITED-STATES | MORTALITY | STROKE | MEDICINE, GENERAL & INTERNAL | CONTROLLED TRIAL | MYOCARDIAL-INFARCTION | DIRECT MEDICAL COSTS | GLUCOSE | SECULAR TRENDS | COMPLICATIONS | CORONARY HEART-DISEASE | Insulin - economics | Markov Chains | Hypoglycemic Agents - economics | United States | Cholesterol - blood | Humans | Middle Aged | Diabetes Mellitus, Type 2 - economics | Pravastatin - economics | Angiotensin-Converting Enzyme Inhibitors - economics | Sulfonylurea Compounds - economics | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Adrenergic beta-Antagonists - economics | Aged, 80 and over | Adult | Diabetic Angiopathies - prevention & control | Diabetic Nephropathies - prevention & control | Pravastatin - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Antihypertensive Agents - economics | Diabetic Neuropathies - economics | Hypoglycemic Agents - therapeutic use | Quality-Adjusted Life Years | Diabetic Angiopathies - economics | Diabetic Neuropathies - prevention & control | Sulfonylurea Compounds - therapeutic use | Anticholesteremic Agents - economics | Diabetes Mellitus, Type 2 - prevention & control | Antihypertensive Agents - therapeutic use | Disease Progression | Diabetic Nephropathies - economics | Anticholesteremic Agents - therapeutic use | Diabetes Mellitus, Type 2 - physiopathology | Cost-Benefit Analysis | Aged | Insulin - therapeutic use | Hypertension | Care and treatment | Hypercholesterolemia | Analysis | Diabetes | Drug therapy | Medical care, Cost of | Cost estimates | Cholesterol
Journal Article
PLoS Medicine, ISSN 1549-1277, 04/2018, Volume 15, Issue 4, p. e1002551
Background Sodium consumption is a modifiable risk factor for higher blood pressure (BP) and cardiovascular disease (CVD). The US Food and Drug Administration... 
UNITED-STATES | TABLE SALT | REDUCTIONS | POPULATION | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR-DISEASE MORTALITY | DIETARY-SODIUM | CORONARY-HEART-DISEASE | URINARY SODIUM | SALT INTAKE | HYPERTENSION | Nutrition Surveys | United States | Humans | Risk Factors | United States Food and Drug Administration - standards | United States Food and Drug Administration - legislation & jurisprudence | Food Handling - standards | Food, Formulated - economics | Computer Simulation | Cost-Benefit Analysis | Nutrition Policy - economics | Hypertension - prevention & control | Food Handling - economics | Sodium, Dietary - administration & dosage | Food-Processing Industry - legislation & jurisprudence | Goals | Food, Formulated - analysis | Food-Processing Industry - economics | Health Policy - economics | Medical policy | Salt | Consumer goods | Laws, regulations and rules | Economic aspects | Nutritional aspects | Public health administration | Cost benefit analysis | Health care | Regulatory agencies | Costs | Compliance | Funding | Cost reduction | Cardiovascular disease | Stomach cancer | Risk factors | Impact analysis | Prevention | Population | Blood pressure | Gastric cancer | Public health | Cost engineering | Food | Consumption | Hypertension | Medical research | Nutrition | Health | Mortality | Preventive medicine | Risk analysis | Cost control | Nutrition research | Health care expenditures | Diet | Sodium | Economic impact | Cost analysis | Cardiovascular diseases | Cancer
Journal Article
European Heart Journal, ISSN 0195-668X, 07/2013, Volume 34, Issue 28, pp. 2149 - 2157
STATEMENT | NERVOUS-SYSTEM | GENERATED SYMPATHETIC ACTIVITY | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | ABLATION | MECHANISMS | RESISTANT ARTERIAL-HYPERTENSION | BLOOD-PRESSURE | ATRIAL-FIBRILLATION | HEMODYNAMICS | Postoperative Complications - economics | Postoperative Complications - etiology | Humans | Hypertension - drug therapy | Catheter Ablation - economics | Surgicenters - statistics & numerical data | Patient Selection | Electrodes | Multicenter Studies as Topic | Insulin Resistance - physiology | Sympathectomy - methods | Surgicenters - economics | Hypertension - economics | Drug Resistance | Antihypertensive Agents - economics | Arrhythmias, Cardiac - prevention & control | Sympathectomy - instrumentation | Treatment Outcome | Hypertension - surgery | Cardio-Renal Syndrome - prevention & control | Antihypertensive Agents - therapeutic use | Randomized Controlled Trials as Topic | Renal Artery - innervation | Catheter Ablation - methods | Diabetes Mellitus - prevention & control | Cost-Benefit Analysis | Catheter Ablation - instrumentation | Renal Artery - surgery | Sympathectomy - economics | methods | Catheter Ablation | Renal Artery | Kardiologi | Cardio-Renal Syndrome | Antihypertensive Agents | instrumentation | innervation | Postoperative Complications | Hypertension | drug therapy | Sympathectomy | Cardiac | Insulin Resistance | physiology | prevention & control | Diabetes Mellitus | etiology | Surgicenters | Cardiac and Cardiovascular Systems | economics | statistics & numerical data | therapeutic use | Arrhythmias | surgery
Journal Article
Heart, ISSN 1355-6037, 04/2017, Volume 103, Issue 7, pp. 483 - 499
ObjectiveThere is an international trend towards recommending medication to prevent cardiovascular disease (CVD) in individuals at increasingly lower... 
DERIVATION | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | STATIN THERAPY | DRUGS | VALIDATION | PEOPLE | BENEFITS | Drug Costs | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Simvastatin - therapeutic use | Dyslipidemias - complications | Tablets | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Simvastatin - economics | Models, Economic | Time Factors | Computer Simulation | Adult | Female | Dyslipidemias - economics | Hypertension - diagnosis | Hypertension - economics | Dyslipidemias - diagnosis | Antihypertensive Agents - economics | Cardiovascular Diseases - diagnosis | Cardiovascular Diseases - economics | Losartan - economics | Quality-Adjusted Life Years | Cardiovascular Diseases - etiology | Dyslipidemias - drug therapy | Primary Prevention - economics | Risk Assessment | Administration, Oral | Risk Factors | Hydroxymethylglutaryl-CoA Reductase Inhibitors - economics | Treatment Outcome | Antihypertensive Agents - therapeutic use | Hydrochlorothiazide - economics | Amlodipine - therapeutic use | Cost-Benefit Analysis | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Losartan - therapeutic use | Primary Prevention - methods | Hypertension - complications | Aged | Amlodipine - economics | Hydrochlorothiazide - therapeutic use | Drug Combinations | Prevention | Cardiovascular diseases | Risk assessment | Analysis
Journal Article
American Journal of Preventive Medicine, ISSN 0749-3797, 2017, Volume 53, Issue 1, pp. 55 - 62
Introduction It is unknown whether there is an interplay of affordability (economic accessibility) and proximity (geographic accessibility) of supermarkets in... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | COSTS | FRUIT | LOCAL FOOD ENVIRONMENT | DESERTS | SOCIOECONOMIC INEQUALITIES | BARRIERS | STOP HYPERTENSION DASH | ATHEROSCLEROSIS RISK | BLOOD-PRESSURE | ACCESS | Hypertension | Epidemiology | Public health | Supermarkets | Chronic diseases | Beverages | Analysis
Journal Article